Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for TFX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1990. Start Trial.
Date Value
July 31, 2026 76.68%
June 30, 2026 76.68%
May 31, 2026 76.68%
April 30, 2026 76.68%
March 31, 2026 76.68%
February 28, 2026 76.68%
January 31, 2026 76.68%
December 31, 2025 75.86%
November 30, 2025 75.86%
October 31, 2025 74.63%
September 30, 2025 74.63%
August 31, 2025 74.63%
July 31, 2025 74.63%
June 30, 2025 72.84%
May 31, 2025 72.21%
April 30, 2025 70.70%
March 31, 2025 69.93%
February 28, 2025 69.48%
January 31, 2025 60.31%
December 31, 2024 60.31%
November 30, 2024 59.09%
October 31, 2024 59.09%
September 30, 2024 59.09%
August 31, 2024 59.09%
July 31, 2024 59.09%
Date Value
June 30, 2024 59.09%
May 31, 2024 59.09%
April 30, 2024 59.09%
March 31, 2024 59.09%
February 29, 2024 59.09%
January 31, 2024 59.09%
December 31, 2023 59.09%
November 30, 2023 59.09%
October 31, 2023 59.09%
September 30, 2023 57.66%
August 31, 2023 57.66%
July 31, 2023 57.66%
June 30, 2023 57.66%
May 31, 2023 57.66%
April 30, 2023 57.66%
March 31, 2023 57.66%
February 28, 2023 57.66%
January 31, 2023 57.66%
December 31, 2022 57.66%
November 30, 2022 57.66%
October 31, 2022 57.66%
September 30, 2022 54.32%
August 31, 2022 49.68%
July 31, 2022 45.86%
June 30, 2022 44.54%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Globus Medical, Inc. 47.91%
Boston Scientific Corp. 60.58%
Alphatec Holdings, Inc. 73.51%
CONMED Corp. 78.74%
DexCom, Inc. 66.32%